News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Twenty early career researchers recently completed the Researcher to Innovator (R2I) programme, an exciting entrepreneurship training programme for researchers with ambitions to develop comm...

UK announces its association to Horizon Europe & Copernicus programmes through a bespoke new agreement with the EU

A rapid COVID-19 antigen test, validated through the Infection Innovation Consortium (iiCON), will be used to deliver large-scale testing across Africa as part of a major FIND and UNITAID pr...

Bionow members will continue to benefit from preferential pricing on liquid gases and associated equipment until 2023

The COVID-19 drug testing platform AGILE, co-led by the University of Liverpool, has received a multi-million pound award from the UK government’s Department of Health and Social Care to f...

Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours with the help of the transnational MATMED prog...

Sygnature has significantly expanded our DMPK capabilities and expertise with the acquisition of XenoGesis, the UK’s largest independent laboratory-based CRO specialising in pre-clinical D...

Inspirational women working in STEM joined forces on Friday 6 March to shine a spotlight on scientific achievements following news that less than 50% of the British public could name a femal...

UP Ventures are delighted to announce today the launch of the Greater Manchester (GM) Future of Health Challenge. To support the initiative UP has assembled a stellar group of Partners and A...

SurgaColl, a regenerative medicine company focused on tissue repair, today announced the completion of its Series A funding, led by the GM&C Life Sciences Fund, and including investment from...

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners